BridgeMD
Compares treatment options for Patellofemoral Pain Syndrome
Official title Popliteus Muscle Release Versus Kinesio Taping
ClinicalTrials.gov ID: NCT07290296
What this study is testing
- What it's testing
- The aim of the current study is to compare the effect of popliteus muscle release and Kinesio taping on pain intensity, function, dynamic balance, and quadriceps muscle strength in patients with patellofemoral pain syndrome.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 30
You may be able to join if
- Patients of both genders with an age range of 18-30 years old.
- minimum 3-month history of patellofemoral pain.
- a pain score for worst pain intensity during the previous week of 3 or more on a Visual Analog Scale (0-10, most pain).
- reproduced by at least two of the following activities: Stair ascent or descent, hopping, running, prolonged sitting, squatting, or kneeling and...
You likely can't join if
- Clinical, x-ray, or MRI findings indicative of other specific pathology, including osteoarthritis, meniscal, ligament, or cartilage injury, or...
- recurrent patellar subluxation or dislocation.
- cortisone use over an extended period of time.
- previous surgery to the knee joint; trauma to the knee joint affecting the presenting clinical condition.
- physiotherapy or other similar exercises for patellofemoral pain syndrome within the previous 3 months.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 30 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.